# Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

> **NCT01084551** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 284 (actual)

## Conditions studied

- Idiopathic Restless Legs Syndrome

## Interventions

- **DRUG:** SPM 962
- **DRUG:** SPM 962
- **DRUG:** Placebo of SPM 962

## Key facts

- **NCT ID:** NCT01084551
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2014-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084551, "Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01084551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*